Abstract A02: SYK kinase inhibition causes autophagy pathway activation via suppression of mTORC1 in KRAS-mutant pancreatic cancer cells

Author(s):  
Kevin L. Hua ◽  
Michelle Pan ◽  
Minoo Rafati ◽  
Anurag Singh
Oncotarget ◽  
2019 ◽  
Vol 10 (10) ◽  
pp. 1056-1069 ◽  
Author(s):  
Austin R. Dosch ◽  
Xizi Dai ◽  
Alexander A. Gaidarski III ◽  
Chanjuan Shi ◽  
Jason A. Castellanos ◽  
...  

2021 ◽  
Vol 10 ◽  
Author(s):  
Huijuan Liu ◽  
Honglian Tao ◽  
Hongqi Wang ◽  
Yuyan Yang ◽  
Ru Yang ◽  
...  

Pancreatic cancer stem cells (CSCs) play an important role in the promotion of invasion and metastasis of pancreatic cancer. Protease activation receptor 1 (PAR1) is closely related to malignant progression of tumors, however, its effects on pancreatic cancer stem cell-like (CSC-like) properties formation have not been reported. In this work, the effects of PAR1 on pancreatic cancer stem cell-like (CSC-like) properties formation were studied. PAR1 overexpression can induce CSC-like properties in Aspc-1 cells, whereas interference of PAR1 in Panc-1 cells showed the contrary results. Data on patients with pancreatic cancer obtained from TCGA showed that high PAR1 expression and focal adhesion kinase (FAK) protein considerably affect the prognosis of patients. Further experiments showed that PAR1 could regulate FAK, PI3K, and AKT phosphorylation and the epithelial–mesenchymal transformation (EMT) in Aspc-1 and Panc-1 cells. Doxycycline, as a PAR1 inhibitor, could effectively inhibit the CSC-like properties of pancreatic cancer cells and the FAK/PI3K/AKT pathway activation. Doxycycline inhibits the growth of pancreatic cancer and enhances the treatment effect of 5-fluorouracil (5-FU) in Panc-1 xenograft mouse model. In conclusion, PAR1 promotes the CSC-like properties and EMT of pancreatic cancer cells via the FAK/PI3K/AKT pathway. Doxycycline inhibits the pancreatic cancer through the PAR1/FAK/PI3K/AKT pathway and enhances the therapeutic effect of 5-FU.


2016 ◽  
Vol 2016 ◽  
pp. 1-11 ◽  
Author(s):  
Lun Zhang ◽  
Jiahui Li ◽  
Jiguang Ma ◽  
Xin Chen ◽  
Ke Chen ◽  
...  

Nrf2 (NF-E2-related factor 2) pathway and autophagy both can respond to oxidative stress to promote cancer cells to survive in the tumor microenvironment. We, therefore, explored the relevance between Nrf2 pathway and autophagy in pancreatic cancer cells upon stimulation of reactive oxygen species (ROS). Pancreatic cancer cells were cultured under controlled ROS stressing condition or basal condition. Different inhibitors were used to prevent autophagy at particular stages. Nrf2 siRNA was used to inhibit Nrf2 pathway activation. Ad-mRFP-GFP-LC3 infection was used to monitor autophagic flux. The result shows that a small amount of exogenous hydrogen peroxide (H2O2) can significantly improve the level of intracellular ROS. Moreover, our findings indicate that ROS promotes the activation of both Nrf2 pathway and autophagy in pancreatic cancer cells. Moreover, our data demonstrate that suppression of autophagic activity at particular stages results in an increased promotion of Nrf2 pathway activation upon ROS stimulation. Furthermore, we found that silencing of Nrf2 promotes autophagy upon ROS stimulation. In addition, Nrf2 interference effectively promotes autophagic flux upon ROS stimulation. In summary, our findings suggest that Nrf2 pathway and autophagy have a negative interaction with each other upon ROS stimulation.


Pancreatology ◽  
2010 ◽  
Vol 10 (1) ◽  
pp. 19-26 ◽  
Author(s):  
Romina Pardo ◽  
Andrea Lo Ré ◽  
Cendrine Archange ◽  
Alejandro Ropolo ◽  
Daniela L. Papademetrio ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Maria Kalli ◽  
Angeliki Minia ◽  
Vaia Pliaka ◽  
Christos Fotis ◽  
Leonidas G. Alexopoulos ◽  
...  

2014 ◽  
Vol 146 (5) ◽  
pp. S-872
Author(s):  
Heloisa P. Soares ◽  
Ming Ming ◽  
Michelle Mellon ◽  
James Sinnett-Smith ◽  
Enrique Rozengurt

Sign in / Sign up

Export Citation Format

Share Document